{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:45:17Z","timestamp":1777592717841,"version":"3.51.4"},"reference-count":75,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,4,15]],"date-time":"2018-04-15T00:00:00Z","timestamp":1523750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,4,15]],"date-time":"2018-04-15T00:00:00Z","timestamp":1523750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1111\/jcpt.12673","type":"journal-article","created":{"date-parts":[[2018,4,15]],"date-time":"2018-04-15T21:16:11Z","timestamp":1523826971000},"page":"519-529","source":"Crossref","is-referenced-by-count":23,"title":["Calcium channel blockers and the incidence of breast and prostate cancer: A meta-analysis"],"prefix":"10.1155","volume":"43","author":[{"given":"A. A.","family":"Thakur","sequence":"first","affiliation":[{"name":"Internal Medicine; Danbury Hospital; Western Connecticut Health Network; Danbury CT USA"},{"name":"Doctor's Hospital at Renaissance Health System; Edinburg TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Mathematics and Statistics; University of Texas-Rio Grande Valley; Edinburg TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Garcia-Betancourt","sequence":"additional","affiliation":[{"name":"Department of Academic Medicine; Doctors Hospital at Renaissance Health System; Edinburg TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Forse","sequence":"additional","affiliation":[{"name":"Doctor's Hospital at Renaissance Health System; Edinburg TX USA"},{"name":"Doctor\u2019s Hospital at Renaissance Health System Clinical Professor of Surgery; University of Texas-Rio Grande Valley; Edinburg TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,4,15]]},"reference":[{"key":"10.1111\/jcpt.12673-BIB0001|jcpt12673-cit-0001","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMra1109345","article-title":"Noncommunicable diseases","volume":"369","author":"Hunter","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12673-BIB0002|jcpt12673-cit-0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/jcpt.12673-BIB0003|jcpt12673-cit-0003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/jcpt.12673-BIB0004|jcpt12673-cit-0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/oxfordjournals.epirev.a036069","article-title":"Prostate cancer: a current perspective","volume":"13","author":"Nomura","year":"1991","journal-title":"Epidemiol Rev"},{"key":"10.1111\/jcpt.12673-BIB0005|jcpt12673-cit-0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10456-014-9420-y","article-title":"Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions","volume":"17","author":"Vasudev","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1111\/jcpt.12673-BIB0006|jcpt12673-cit-0006","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbabio.2017.01.003","article-title":"Calcium regulates cell death in cancer: roles of the mitochondria and mitochondria-associated membranes (MAMs)","volume":"1858","author":"Danese","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jcpt.12673-BIB0007|jcpt12673-cit-0007","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/jnci\/86.17.1286","article-title":"Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators","volume":"86","author":"Stewart","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/jcpt.12673-BIB0008|jcpt12673-cit-0008","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bjc.1993.40","article-title":"Apoptosis (the 1992 Frank Rose Memorial Lecture)","volume":"67","author":"Wyllie","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1111\/jcpt.12673-BIB0009|jcpt12673-cit-0009","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1469-185X.1992.tb00727.x","article-title":"Programmed cell death: concept, mechanism and control","volume":"67","author":"Sen","year":"1992","journal-title":"Biol Rev Camb Philos Soc"},{"key":"10.1111\/jcpt.12673-BIB0010|jcpt12673-cit-0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1574892811308010004","article-title":"The need for calcium channels in cell proliferation","volume":"8","author":"Capiod","year":"2013","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1111\/jcpt.12673-BIB0011|jcpt12673-cit-0011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0167-4889(94)00233-5","article-title":"Ca2\u00a0+\u00a0\/Mg(2\u00a0+\u00a0)-dependent endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro","volume":"1266","author":"Sokolova","year":"1995","journal-title":"Biochem Biophys Acta"},{"key":"10.1111\/jcpt.12673-BIB0012|jcpt12673-cit-0012","doi-asserted-by":"crossref","first-page":"15467","DOI":"10.1007\/s13277-016-5353-y","article-title":"Regulation of autophagy by Ca2+","volume":"37","author":"Sun","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1111\/jcpt.12673-BIB0013|jcpt12673-cit-0013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nchembio.79","article-title":"Novel targets for Huntington's disease in an mTOR-independent autophagy pathway","volume":"4","author":"Williams","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1111\/jcpt.12673-BIB0014|jcpt12673-cit-0014","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/j.1875-9114.1997.tb03732.x","article-title":"Calcium channel blockers: the present and the future","volume":"17","author":"Pieper","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12673-BIB0015|jcpt12673-cit-0015","doi-asserted-by":"crossref","first-page":"e113649","DOI":"10.1371\/journal.pone.0113649","article-title":"Nifedipine promotes the proliferation and migration of breast cancer cells","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12673-BIB0016|jcpt12673-cit-0016","unstructured":"Wells GA Shea B O'connell D The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2014 http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"10.1111\/jcpt.12673-BIB0017|jcpt12673-cit-0017","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"10.1111\/jcpt.12673-BIB0018|jcpt12673-cit-0018","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2307\/3001616","article-title":"Some Methods for Strengthening the Common &#x3c7;<sup>2\u00a0<\u00a0\/sup> Tests","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1111\/jcpt.12673-BIB0019|jcpt12673-cit-0019","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1111\/jcpt.12673-BIB0020|jcpt12673-cit-0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/EDE.0000000000000483","article-title":"Use of calcium channel blockers and risk of breast cancer: a population-based cohort study","volume":"27","author":"Azoulay","year":"2016","journal-title":"Epidemiology"},{"key":"10.1111\/jcpt.12673-BIB0021|jcpt12673-cit-0021","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10552-012-0122-8","article-title":"Use of antihypertensive medications and breast cancer risk","volume":"24","author":"Saltzman","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1111\/jcpt.12673-BIB0022|jcpt12673-cit-0022","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.0.CO;2-3","article-title":"Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses\u2019 health study","volume":"83","author":"Michels","year":"1998","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12673-BIB0023|jcpt12673-cit-0023","doi-asserted-by":"crossref","first-page":"e009147","DOI":"10.1136\/bmjopen-2015-009147","article-title":"Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)","volume":"6","author":"Grimaldi-Bensouda","year":"2016","journal-title":"BMJ Open"},{"key":"10.1111\/jcpt.12673-BIB0024|jcpt12673-cit-0024","doi-asserted-by":"crossref","first-page":"e50893","DOI":"10.1371\/journal.pone.0050893","article-title":"Long-term use of angiotensin receptor blockers and the risk of cancer","volume":"7","author":"Azoulay","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12673-BIB0025|jcpt12673-cit-0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(02)00157-0","article-title":"Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study","volume":"39","author":"Beiderbeck-Noll","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1111\/jcpt.12673-BIB0026|jcpt12673-cit-0026","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1001\/jamainternmed.2014.3867","article-title":"Breast cancer risk and use of calcium channel blockers using Swedish population registries","volume":"174","author":"Bergman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1111\/jcpt.12673-BIB0027|jcpt12673-cit-0027","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0735-1097(98)00008-4","article-title":"Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Bezafibrate Infarction Prevention (BIP) Study Research Group","volume":"31","author":"Braun","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jcpt.12673-BIB0028|jcpt12673-cit-0028","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1055-9965.EPI-03-0093","article-title":"Inverse association between prostate cancer and the use of calcium channel blockers","volume":"13","author":"Debes","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/jcpt.12673-BIB0029|jcpt12673-cit-0029","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10549-015-3311-9","article-title":"Antihypertensive medication use and incident breast cancer in women","volume":"150","author":"Devore","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/jcpt.12673-BIB0030|jcpt12673-cit-0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.canep.2013.09.001","article-title":"Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study","volume":"37","author":"Holmes","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1111\/jcpt.12673-BIB0031|jcpt12673-cit-0031","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(97)80084-0","article-title":"Calcium-channel blockers and risk of cancer","volume":"349","author":"Jick","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12673-BIB0032|jcpt12673-cit-0032","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","article-title":"Calcium-channel blockade and incidence of cancer in aged populations","volume":"348","author":"Pahor","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12673-BIB0033|jcpt12673-cit-0033","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.279.13.1000","article-title":"Calcium channel blockers and the risk of cancer","volume":"279","author":"Rosenberg","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12673-BIB0034|jcpt12673-cit-0034","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G","article-title":"Cancer risk and mortality in users of calcium channel blockers. A cohort study","volume":"89","author":"Sorensen","year":"2000","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12673-BIB0035|jcpt12673-cit-0035","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6","article-title":"Use of calcium channel blockers and breast carcinoma risk in postmenopausal women","volume":"80","author":"Fitzpatrick","year":"1997","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12673-BIB0036|jcpt12673-cit-0036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004872-199816010-00017","article-title":"Cancer risk of hypertensive patients taking calcium antagonists","volume":"16","author":"Hole","year":"1998","journal-title":"J Hypertens"},{"key":"10.1111\/jcpt.12673-BIB0037|jcpt12673-cit-0037","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archinte.160.3.349","article-title":"Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer","volume":"160","author":"Meier","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12673-BIB0038|jcpt12673-cit-0038","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/cncr.11663","article-title":"Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79\u00a0years","volume":"98","author":"Li","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12673-BIB0039|jcpt12673-cit-0039","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-007-9135-0","article-title":"Medication use and the risk of breast cancer","volume":"22","author":"Davis","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/jcpt.12673-BIB0040|jcpt12673-cit-0040","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/pds.1656","article-title":"Long-term use of antihypertensive drugs and risk of cancer","volume":"17","author":"Assimes","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12673-BIB0041|jcpt12673-cit-0041","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jamainternmed.2013.9071","article-title":"Use of antihypertensive medications and breast cancer risk among women aged 55 to 74\u00a0years","volume":"173","author":"Li","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1111\/jcpt.12673-BIB0042|jcpt12673-cit-0042","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40119-015-0035-1","article-title":"Long-term use of antihypertensive agents and risk of breast cancer: a population-based case-control study","volume":"4","author":"Leung","year":"2015","journal-title":"Cardiol Ther"},{"key":"10.1111\/jcpt.12673-BIB0043|jcpt12673-cit-0043","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1200\/JCO.2009.27.9406","article-title":"Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey","volume":"28","author":"Chang","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12673-BIB0044|jcpt12673-cit-0044","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0895-7061(98)00176-9","article-title":"Calcium channel blocker use and the risk of prostate cancer","volume":"11","author":"Vezina","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1111\/jcpt.12673-BIB0045|jcpt12673-cit-0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1047-2797(01)00246-0","article-title":"Hypertension, heart rate, use of antihypertensives, and incident prostate cancer","volume":"11","author":"Fitzpatrick","year":"2001","journal-title":"Ann Epidemiol"},{"key":"10.1111\/jcpt.12673-BIB0046|jcpt12673-cit-0046","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1023\/B:CACO.0000036152.58271.5e","article-title":"Antihypertensive drug use and the risk of prostate cancer (Canada)","volume":"15","author":"Perron","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1111\/jcpt.12673-BIB0047|jcpt12673-cit-0047","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pros.10294","article-title":"Association between captopril, other antihypertensive drugs and risk of prostate cancer","volume":"58","author":"Ronquist","year":"2004","journal-title":"Prostate"},{"key":"10.1111\/jcpt.12673-BIB0048|jcpt12673-cit-0048","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10552-008-9280-0","article-title":"Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort","volume":"20","author":"Rodriguez","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1111\/jcpt.12673-BIB0049|jcpt12673-cit-0049","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10552-011-9819-3","article-title":"The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case-control study","volume":"22","author":"Kemppainen","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1111\/jcpt.12673-BIB0050|jcpt12673-cit-0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/HJH.0000000000000813","article-title":"Antihypertensive agents and the risk of breast cancer in women aged 55\u00a0years and older: a nested case-control study","volume":"34","author":"Chang","year":"2016","journal-title":"J Hypertens"},{"key":"10.1111\/jcpt.12673-BIB0051|jcpt12673-cit-0051","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/pds.910","article-title":"Breast cancer incidence and use of antihypertensive medication in women","volume":"13","author":"Gonzalez-Perez","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/jcpt.12673-BIB0052|jcpt12673-cit-0052","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12672-016-0259-0","article-title":"The metabolism, analysis, and targeting of steroid hormones in breast and prostate cancer","volume":"7","author":"Capper","year":"2016","journal-title":"Horm Cancer"},{"key":"10.1111\/jcpt.12673-BIB0053|jcpt12673-cit-0053","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00216645","article-title":"An ultrastructural study of mitosis and cytokinesis in normal \u2018resting\u2019 human breast","volume":"252","author":"Ferguson","year":"1988","journal-title":"Cell Tissue Res"},{"key":"10.1111\/jcpt.12673-BIB0054|jcpt12673-cit-0054","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsbmb.2016.11.017","article-title":"Different epigenetic mechanisms of ERalpha implicated in the fate of fulvestrant-resistant breast cancer","volume":"167","author":"Tsuboi","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1111\/jcpt.12673-BIB0055|jcpt12673-cit-0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1111\/jcpt.12673-BIB0056|jcpt12673-cit-0056","doi-asserted-by":"crossref","first-page":"C515","DOI":"10.1152\/ajpcell.00330.2013","article-title":"Cellular calcium dynamics in lactation and breast cancer: from physiology to pathology","volume":"306","author":"Cross","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/jcpt.12673-BIB0057|jcpt12673-cit-0057","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-016-0720-6","article-title":"Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women","volume":"18","author":"Wilson","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1111\/jcpt.12673-BIB0058|jcpt12673-cit-0058","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/15384047.2016.1235656","article-title":"Activation of estrogen receptor alpha by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells","volume":"18","author":"Matsumura","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"10.1111\/jcpt.12673-BIB0059|jcpt12673-cit-0059","doi-asserted-by":"crossref","first-page":"22443","DOI":"10.18632\/oncotarget.12338","article-title":"MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG\/Ras\/ERK signaling axis","volume":"8","author":"Ho","year":"2016","journal-title":"Oncotarget"},{"key":"10.1111\/jcpt.12673-BIB0060|jcpt12673-cit-0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00048064","article-title":"Active cell death in hormone-dependent tissues","volume":"11","author":"Tenniswood","year":"1992","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/jcpt.12673-BIB0061|jcpt12673-cit-0061","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jcb.25783","article-title":"P-glycoprotein inhibition sensitizes human breast cancer cells to proteasome inhibitors","volume":"118","author":"Deshmukh","year":"2016","journal-title":"J Cell Biochem"},{"key":"10.1111\/jcpt.12673-BIB0062|jcpt12673-cit-0062","doi-asserted-by":"crossref","first-page":"36353","DOI":"10.18632\/oncotarget.9217","article-title":"DNA damaging agent-induced apoptosis is regulated by MCL-1 phosphorylation and degradation mediated by the Noxa\/MCL-1\/CDK2 complex","volume":"7","author":"Nakajima","year":"2016","journal-title":"Oncotarget"},{"key":"10.1111\/jcpt.12673-BIB0063|jcpt12673-cit-0063","doi-asserted-by":"crossref","first-page":"a001222","DOI":"10.1101\/cshperspect.a001222","article-title":"p53-based cancer therapy","volume":"2","author":"Lane","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1111\/jcpt.12673-BIB0064|jcpt12673-cit-0064","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.urolonc.2013.08.001","article-title":"Calcium channel blockers and prostate cancer","volume":"32","author":"Loughlin","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1111\/jcpt.12673-BIB0065|jcpt12673-cit-0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.urolonc.2013.05.011","article-title":"Cav1.3 channel alpha1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers","volume":"32","author":"Chen","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1111\/jcpt.12673-BIB0066|jcpt12673-cit-0066","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1109\/TNSRE.2006.870490","article-title":"The effect of random modulation of functional electrical stimulation parameters on muscle fatigue","volume":"14","author":"Graham","year":"2006","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"10.1111\/jcpt.12673-BIB0067|jcpt12673-cit-0067","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1055\/s-2007-1001738","article-title":"Calcium and prolactin secretion in humans: effects of the channel blocker, verapamil, in the spontaneous and drug-induced hyperprolactinemia","volume":"26","author":"Knoepfelmacher","year":"1994","journal-title":"Horm Metab Res"},{"key":"10.1111\/jcpt.12673-BIB0068|jcpt12673-cit-0068","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2164\/jandrol.106.000554","article-title":"Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells","volume":"27","author":"Sun","year":"2006","journal-title":"J Androl"},{"key":"10.1111\/jcpt.12673-BIB0069|jcpt12673-cit-0069","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1007727010076","article-title":"Calcium channel blockers and the risk of cancer: a preclinical assessment","volume":"12","author":"Ahr","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1111\/jcpt.12673-BIB0070|jcpt12673-cit-0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/pros.2990190404","article-title":"Effect of calcium and calcium antagonists on 45Ca influx and cellular growth of human prostatic tumor cells","volume":"19","author":"Batra","year":"1991","journal-title":"Prostate"},{"key":"10.1111\/jcpt.12673-BIB0071|jcpt12673-cit-0071","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2093::AID-CNCR1>3.0.CO;2-E","article-title":"Effects of calcium channel blockers on cellular apoptosis: implications for carcinogenic potential","volume":"85","author":"Mason","year":"1999","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12673-BIB0072|jcpt12673-cit-0072","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0895-7061(98)00120-4","article-title":"Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist","volume":"11","author":"Sharifi","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1111\/jcpt.12673-BIB0073|jcpt12673-cit-0073","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00125-001-0765-6","article-title":"Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model","volume":"45","author":"Jesmin","year":"2002","journal-title":"Diabetologia"},{"key":"10.1111\/jcpt.12673-BIB0074|jcpt12673-cit-0074","unstructured":"Control C Prostate Cancer Rates by Race and Ethnicity https:\/\/www.cdc.gov\/cancer\/prostate\/statistics\/race.htm"},{"key":"10.1111\/jcpt.12673-BIB0075|jcpt12673-cit-0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/HPC.0b013e318053da59","article-title":"The management of hypertension in African Americans","volume":"6","author":"Ferdinand","year":"2007","journal-title":"Crit Pathw Cardiol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12673","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12673\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T01:13:42Z","timestamp":1720228422000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,15]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12673","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4,15]]}}}